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Introduction
Systemic lupus erythematosus (SLE) is a chronic inflamma-
tory autoimmune disease, whose treatment with corticoste-
roids and immunosuppressive drugs contributes to the onset 
of opportunistic infection by Mycobacterium tuberculosis.1,2 
The extrapulmonary form of tuberculosis predominates in 
patients with lupus.1 This bacterium can affect the middle 
ear trough the Eustachian tube or externally by tympan-
ic perforation.3,4 Tuberculous otitis media (TOM) is a rare 
disease, accounting for 0.05% to 0.9% of chronic otitis me-
dia,4,5 although it is significantly more common in SLE (3.6% 
to 11.6%).2 The clinical triad of TOM is painless otorrhea, 
tympanic membrane perforation, and facial paralysis; ear 
pain can also be present.4 Late diagnosis of TOM is common 
and associated with complications such as mastoiditis and 
hearing loss.3 The present case is a report of tuberculous 
otomastoiditis in an adult patient with SLE. 
Case report
ILS, a 44-year-old female homemaker complained of sudden 
fullness in the left ear a year before, followed by daily se-
rosanguineous to purulent otorrhea, with progressive hear-
ing loss and tinnitus. She denied prior otorrhea, vertigo, or 
contact with tuberculosis. She had received prior treatment 
with amoxicillin/clavulanate, ciprofloxacin, and topical gen-
tamicin/betamethasone. The patient had SLE, controlled 
with prednisone 10 mg/day. She had no cervical lymphade-
nopathy and the oral cavity, pharynx, and rhinoscopy were 
normal, with normal VII function bilaterally. The right otos-
copy was normal; the left otoscopy disclosed whitish mucous 
secretion at the bottom of the ear canal. Laboratory tests 
were normal. Computed tomography (CT) showed pneu-
matized mastoids, with the left appearing opaque without 
erosions. Audiometry showed ipsilateral moderate mixed 
hearing loss. Chronic suppurative otitis media (CSOM) was 
suspected. A tympanomastoidectomy was performed, which 
disclosed friable whitish tissue in the mastoid and middle 
ear without cholesteatoma, anvil erosion, or misidentified 
stirrup. A mastoid debridement was performed, followed by 
specimen collection and fascia graft. Ossiculoplasty was left 
for a subsequent procedure.
The patient evdeveloped tinnitus, progressive wound 
dehiscence, otorrhea, and  afacial paresis that recovered in 
three weeks. She was started on azathioprine and predni-
sone 40 mg. Two months later, the mastoid was fully exposed 
(Fig. 1), and tuberculosis was suspected. The material col-
lected during surgery was insufficient to establish the diag-
nosis. She had a non-reactive PPD and normal chest X-ray. 
A biopsy performed through the dehiscent incision showed 
extensive granulomatous reaction with, giant multinucleated 
epithelioid cells with focal necrotic areas. Fungus and AFB 
culture results were negative. Considering these data, the 
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physicians decided to establish an early antituberculosis reg-
imen: rifampicin, isoniazid, pyrazinamide, and ethambutol 
for two months, followed by isoniazid and rifampicin for sev-
en months.6 Improvement in healing was observed after 30 
days (Fig. 1). After three months, the incision was closed.
One year later, she remained with tinnitus, discrete 
otorrhea, and tympanic perforation. Audiometry showed no 
responses at 6 and 8 kHz, with preservation of thresholds at 
the other frequencies.
Discussion
The scarcity of TOM reports delays diagnosis.3-5 In this case, 
the investigation was prompted by the unfavorable evolu-
tion (wound dehiscence). The initial clinical presentation 
suggested CSOM with more aggressive evolution, which was 
attributed to the use of corticosteroids and SLE.1,2 Perhaps 
the foreknowledge that TOM in SLE is much more common 
than in the general population2 would have led to a more 
unequivocal investigation of this disease and more thorough 
consideration of surgical indication.
However, it is difficult to say whether the diagnosis 
would be confirmed without surgery, due to the greater 
difficulty in collecting expressive material. Even with the 
abundant material collected through the incision dehis-
cence, a definitive diagnosis was not possible, which is con-
sistent with the literature that indicates difficulty in the 
etiological diagnosis;3,5 this diagnosis is confirmed only by 
prompt improvement in evolution after starting the anti-
tuberculosis medication. Another aspect to be discussed is 
the tomographic image showing normal mastoid pneumati-
zation, not expected in cases of CSOM, which should alert 
the clinician of rarer diagnostic possibilities.3
Final considerations 
Immunosuppressive conditions, such as lupus and other au-
toimmune diseases, as well as the use of corticosteroids, 
associated with atypical behavior of otitis or other otorhi-
nolaryngology infections, should alert the physician to the 
presence of specific infections, and among them, tuber-
culosis.
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Figur 1 Dehiscent retroauricular incision. Left image: aspect 
80 days after surgery; and on the right: 30 days after start of 
treatment for tuberculosis, showing improved healing.
